BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 14972392)

  • 1. MRI characterization of residual mediastinal masses in Hodgkin's disease: long-term follow-up.
    Di Cesare E; Cerone G; Enrici RM; Tombolini V; Anselmo P; Masciocchi C
    Magn Reson Imaging; 2004 Jan; 22(1):31-8. PubMed ID: 14972392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of magnetic resonance imaging and (67)gallium scintigraphy in the evaluation of posttherapeutic residual mediastinal mass in the patients with Hodgkin's lymphoma.
    Herman M; Paucek B; Raida L; Myslivecek M; Zapletalová J
    Eur J Radiol; 2007 Dec; 64(3):432-8. PubMed ID: 17478069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gd-DTPA-enhanced MR imaging in mediastinal Hodgkin's disease.
    Forsgren G; Nyman R; Glimelius B; Hagberg H; Rehn S; Hemmingsson A
    Acta Radiol; 1994 Nov; 35(6):564-9. PubMed ID: 7946679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Malignant lymphoma: magnetic resonance tomography findings in residual supradiaphragmatic space-occupying lesions].
    Stroszczynski C; Hosten N; Oellinger J; Spahn G; Amthauer H; Bittner RC; Hierholzer J; Ludwig WD; Felix R
    Rofo; 1999 Sep; 171(3):192-9. PubMed ID: 10520328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Magnetic resonance in the study of residual mediastinal masses after therapy of lymphoma].
    Davini O; Levis A; Garabello D; Foggetti MD; Depaoli L; Cirillo R; De Lucchi R; Orsucci L; Resegotti L
    Radiol Med; 1992 Mar; 83(3):230-6. PubMed ID: 1579671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mediastinal lymphoma: quantitative changes in gadolinium enhancement at MR imaging after treatment.
    Rahmouni A; Divine M; Lepage E; Jazaerli N; Belhadj K; Gaulard P; Golli M; Reyes F; Vasile N
    Radiology; 2001 Jun; 219(3):621-8. PubMed ID: 11376245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term follow-up of residual mediastinal masses in treated Hodgkin's disease using MR imaging.
    Nyman R; Forsgren G; Glimelius B
    Acta Radiol; 1996 May; 37(3 Pt 1):323-6. PubMed ID: 8845262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pigmented villonodular synovitis (PVNS) of the knee joint: magnetic resonance imaging (MRI) using standard and dynamic paramagnetic contrast media. Report of 52 cases surgically and histologically controlled.
    Barile A; Sabatini M; Iannessi F; Di Cesare E; Splendiani A; Calvisi V; Masciocchi C
    Radiol Med; 2004 Apr; 107(4):356-66. PubMed ID: 15103287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic accuracy of chemical-shift MR imaging to differentiate between adrenal adenomas and non adenoma adrenal lesions.
    Maurea S; Imbriaco M; D'Angelillo M; Mollica C; Camera L; Salvatore M
    Radiol Med; 2006 Aug; 111(5):674-86. PubMed ID: 16791464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamic contrast enhanced MRI in the differential diagnosis of adrenal adenomas and malignant adrenal masses.
    Inan N; Arslan A; Akansel G; Anik Y; Balci NC; Demirci A
    Eur J Radiol; 2008 Jan; 65(1):154-62. PubMed ID: 17466481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Does residual mediastinal mass in children with completed treatment of Hodgkin's disease affect the incidence of relapses?].
    Balwierz W; Armata J; Moryl-Bujakowska A; Depowska T; Bogusławska-Jaworska J; Pisarek J; Sońta-Jakimczyk D; Janik-Moszant A; Rokicka-Milewska R; Sopyło B; Kołakowska-Mrozowska B; Radwańska U; Kołecki P; Kaczmarek-Kanold M; Kowalczyk J; Skomra S; Ochocka M; Matysiak M; Newecka-Samól T
    Wiad Lek; 1998; 51 Suppl 4():12-7. PubMed ID: 10731938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Does the residual mediastinal mass have prognostic significance in children with Hodgkin's disease (HD)?].
    Klekawka T; Balwierz W; Moryl-Bujakowska A; Stanuch H; Matysiak M; Rokicka-Milewska R; Sopyło B; Kołakowska-Mrozowska B; Krenke K; Chybicka A; Chaber R; Sońita-Jakimczyki D; Janik-Moszants A; Wachowiak J; Kaczmarek-Kanold M; Kowalczyk J; Odój T; Balcerska A; Adamkiewicz-Drozyińska E; Wysocki M; Koltan A; Krawczuk-Rybako M; Muszyńska-Rosłan K; Stolarska M
    Przegl Lek; 2006; 63(1):21-4. PubMed ID: 16892894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Staging and re-staging of soft tissue sarcoma using MRI. Usefulness of contrast media].
    Barile A; Caulo M; Zugaro L; Di Cesare E; Gallucci M; Masciocchi C
    Radiol Med; 2001 Jun; 101(6):444-55. PubMed ID: 11479441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of Gd-BOPTA and Gd-DTPA in contrast-enhanced MR imaging of the liver].
    Zhang HM; Ouyang H; Zhou CW
    Zhonghua Zhong Liu Za Zhi; 2006 Feb; 28(2):111-5. PubMed ID: 16750014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteosarcoma: preliminary results of in vivo assessment of tumor necrosis after chemotherapy with diffusion- and perfusion-weighted magnetic resonance imaging.
    Uhl M; Saueressig U; van Buiren M; Kontny U; Niemeyer C; Köhler G; Ilyasov K; Langer M
    Invest Radiol; 2006 Aug; 41(8):618-23. PubMed ID: 16829744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic value of contrast-enhanced fluid-attenuated inversion-recovery MRI for intracranial tumors in comparison with post-contrast T1W spin-echo MRI.
    Zhou ZR; Shen TZ; Chen XR; Peng WJ
    Chin Med J (Engl); 2006 Mar; 119(6):467-73. PubMed ID: 16584644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced mass on contrast-enhanced breast MR imaging: Lesion characterization using combination of dynamic contrast-enhanced and diffusion-weighted MR images.
    Yabuuchi H; Matsuo Y; Okafuji T; Kamitani T; Soeda H; Setoguchi T; Sakai S; Hatakenaka M; Kubo M; Sadanaga N; Yamamoto H; Honda H
    J Magn Reson Imaging; 2008 Nov; 28(5):1157-65. PubMed ID: 18972357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between contrast enhancement on fluid-attenuated inversion recovery MR sequences and signal intensity on T2-weighted MR images: visual evaluation of brain tumors.
    Kubota T; Yamada K; Kizu O; Hirota T; Ito H; Ishihara K; Nishimura T
    J Magn Reson Imaging; 2005 Jun; 21(6):694-700. PubMed ID: 15906343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diagnostic evaluation of chronic inflammatory intestinal diseases in children and adolescents: MRI with true-FISP as new gold standard?].
    Hohl C; Haage P; Krombach GA; Schmidt T; Ahaus M; Günther RW; Staatz G
    Rofo; 2005 Jun; 177(6):856-63. PubMed ID: 15902636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diagnosis of glomus jugulare tumor recurrence with dynamic contrast medium flow in MRI].
    Greess H; Bentzien S; Gjuric M; Lell M; Lenz M; Bautz W
    Rofo; 2000 Sep; 172(9):753-8. PubMed ID: 11079088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.